The health care system is poorly designed to empower individuals to manage their health, particularly as part of their daily lives (outside of clinics). The pandemic has placed this long-standing challenge in stark relief as individuals engage less with their doctors in the clinical setting. This puts a premium on engaging individuals on their terms acknowledging their daily context. In this webinar, a panel of experts -- representing patient advocacy, cardiology, pharmaceutical, and health technology -- will discuss approaches for empowering individuals with heart conditions to act on best insights tailored to their specific situation (in a permissioned manner). 

Featured Speakers

John S. Rumsfeld, MD, PhD

Chief Innovation Officer
American College of Cardiology

Dr. Rumsfeld is the Chief Innovation Officer and Chief Science Officer for the American College of Cardiology (ACC). He is a Professor of Medicine at the University of Colorado School of Medicine, and an Attending Cardiologist at the VA Rocky Mountain Region Medical Center.

Previously, Dr. Rumsfeld served as National Director for Cardiology for the U.S. Department of Veterans Affairs (VA) (2012-2017), and as Chief Science Officer for the ACC's National Cardiovascular Data Registry (NCDR) programs (2005-2016).  He also founded and served as the inaugural National Director for the VA’s Clinical Assessment Reporting and Tracking program (national clinical quality and analytics program) (2009-2016).

Kalahn A. Taylor-Clark, PhD, MPH

VP and Global Head, Patient-Centered Outcomes and Innovation

Kalahn Taylor-Clark, PhD, MPH is the Global Head of Patient Solutions at Sanofi. Dr. Taylor-Clark serves as the strategic patient lead to global business units in the US/EU and China and Emerging Markets, across all therapeutic areas of the company. Her team is responsible for supporting patient-focused risk-benefit analyses, improving digital strategies and new technology use to better capture patients’ perspectives, and translating Real World Evidence (RWE) studies into high impact solutions to improve patient adherence and outcomes. Prior to this post Taylor-Clark served as the US Head of Public Affairs in Cardiometabolic Health. Taylor-Clark’s work has helped the company to develop, measure, amplify and adapt solutions based on key stakeholder input (e.g. providers, patients, scientific societies and policymakers), that align to emphasize increased access to innovation and improved patient-relevant outcomes.

Mikki Nasch

Co-founder and VP of Business Development
Evidation Health

Mikki is the Co-founder and VP of Business Development at Evidation Health. At Evidation, Mikki is responsible for revenue and strategic business development. Prior to co-founding Evidation, she was the EVP of Business Development for Sense Networks, a pioneering machine learning company founded by leading scientists at MIT and Columbia. She has held executive roles at Fair Isaac (NYSE: FIC) and leadership positions in the incubation phase of numerous startups. A serial technology entrepreneur, Mikki was part of the founding team of Backweb Technologies (NASD: BWEB) and managed business development projects at AT&T Business Network (, Europe Online, and Reuters. Mikki is on the Advisory Committee for Goergen Institute for Data Science at the University of Rochester.


Register now for this webinar